Drug makers and payers have these challenges to implement outcomes-based contracts, but here are three steps that can be taken as a transition toward these payment arrangements.
Pharmacy Best Practices
Here are three innovative structures in pricing models to address the high-cost of curative therapies.
Here's how one federally qualified health center in southcentral Pennsylvania is tackling the opioid crisis in its community.
A study from the Intermountain Medical Center Heart Institute has shocking findings about certain blood pressure medications and mortality outcomes.
Attending the AMCP Managed Care and Specialty Pharmacy Annual Meeting in Boston April 23 to April 26? Here are our top session recommendations.
Diabetes drug spending is on the rise, but there are ways to control it.
A new Oliver Wyman study reveals costly findings about Part D beneficiaries enrolled in plans without preferred pharmacy networks.
We know you’re pressed for time, so we’re here to help. Listen to this two-minute podcast for critical takeaways from three of our top articles.
PBMs are in a unique position to leverage three critical tools to protect patients from unnecessary healthcare costs.
Experts weigh in on a recent lawsuit against PBMs, whether similar lawsuits will crop up, and the likely outcomes.